-
Thematic Analysis
New![]()
Internet of Things (IoT) in Sport – Thematic Intelligence
Internet of Things (IoT) in Sport Thematic Report Overview IoT has been emerging as an integral strategy in sports to enhance fan engagement. Â Sports enthusiasts are increasingly tuning in to digital platforms, like streaming apps, to watch their favorite sports. In turn, this trend provides sporting organizations a chance to develop a closer relationship with fans. Leading clubs are developing apps that make fans feel more connected to the club than ever before. Clubs that can demonstrate high levels of...
-
Company Insights
New![]()
BHP – Digital Transformation Strategies
BHP has been leveraging machine learning technologies to bring disruptive changes in its business processes and has initiated various in-house strategies to drive digital transformation. The annual ICT spending of BHP was estimated at $398.2 million in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. BHP is a mineral resources company engaged in exploring, acquiring, developing, and marketing various commodities including iron ore, coal, nickel, copper, lead, silver, molybdenum, uranium,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Imvotamab in Systemic Lupus Erythematosus
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Imvotamab in Systemic Lupus Erythematosus Drug Details: Imvotamab is under development for the treatment of...
-
Sector Analysis
New![]()
APAC Non-Alcoholic Beverages Sports Sponsorship Landscape, 2023 – Analysing Biggest Deals, Sports League, Brands and Case Studies
The non-alcoholic beverages sector accounts for an estimated annual spend of $83.09 million in sports sponsorship in APAC for 2023. There are 179 different brands currently engaged in sports sponsorship agreements across APAC. Coca-Cola is the most active brand in the sector in 2023, thanks to partnerships with organizations and teams including V8 Supercars Australia, Thai League 1, and FC Seoul. Coca-Cola’s total sponsorship spend within APAC accounts for more than 17 percent of total sector spend within the region....
-
Company Insights
New![]()
Business of the MotoGP 2023 – Property Profile, Sponsorship and Media Landscape
Business of the MotoGP 2023 Report Overview The estimated annual sponsorship revenue of MotoGP 2023 is $87.95 million in 2023. MotoGP continues to be the premier global motorcycling competition and includes 20 different Grand Prix races this season. The series has 26 sponsors overall for the 2023 season. Business of The MotoGP 2023 research report explores one of the biggest and most commercial motor racing series for the 2023 season. It takes a closer look at the main sponsorship and...
-
Track & Monitor
New![]()
Innovation in Pharmaceuticals: Platinum as active pharmaceutical ingredient
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Thematic Analysis
New![]()
Internet of Things (IoT) in Energy – Thematic Intelligence
Internet of Things (IoT) in Energy Thematic Report Overview The Internet of Things (IoT) can create a tech ecosystem that addresses many challenges within the energy sector such as balancing supply with demand, workplace safety, integrating renewable energy into the grid, and fluctuating energy prices. For instance, the predictive maintenance capabilities of IoT can significantly transform the energy sector by optimizing operations, managing asset performance, and engaging customers to lower energy costs. The energy sector has already reaped benefits from...
-
Thematic Analysis
![]()
Insurtech – Thematic Intelligence
Insurtech Thematic Report Overview Insurtechs can create innovative solutions for content generation using generative AI, risk modeling, and customer engagement. For instance, they can use generative AI to generate personalized insurance policies based on customer data, enhancing customer experiences and increasing policy uptake. Additionally, generative AI can be utilized to create interactive chatbots or virtual assistants that provide real-time support and streamline claims processing. Thus, by leveraging generative AI's ability to generate new content, insurtechs can also improve marketing efforts,...
-
Sector Analysis
New![]()
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
The report provides an in-depth assessment of the Myasthenia gravis market including disease overview, epidemiology, current treatment options, unmet needs and opportunities, R&D strategies, pipeline assessment, and market outlook.
-
Track & Monitor
New![]()
Innovation in medical: transdermal drug delivery
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the medical industry’s Transdermal drug delivery innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience...
-
Track & Monitor
New![]()
Innovation in pharma: transdermal drug delivery
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the pharma industry’s transdermal drug delivery innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience...
-
Case Studies
![]()
Scrub Daddy – Success Case Study
Scrub Daddy - Success Case Study is part of GlobalData's Success and Failures case study series, which explores the reasons underpinning success or failure, and key learnings. Scrub Daddy is a premium scouring product that has attracted a huge online following and used TV show "Shark's Den" as a part of the springboard to success. Scrub Daddy has managed to capture the attention of consumers in an otherwise low-engagement category by smart use of social media. The product itself leans...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Obexelimab in Acquired (Autoimmune) Hemolytic Anemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Obexelimab in Acquired (Autoimmune) Hemolytic Anemia Drug Details: Obexelimab (XmAb-5871) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AMX-818 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.AMX-818 in Solid Tumor Drug Details: AMX-818 is under development for the treatment of HER2 low...
-
Track & Monitor
New![]()
Artificial intelligence in Insurance: Dynamic premium pricing
Innovation in the insurance industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in insurance industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Track & Monitor
New![]()
Internet of Things in Automotive: Smart factory systems
Innovation in the automotive industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in automotive industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) Drug Details: Obexelimab (XmAb-5871) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – JANX-007 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.JANX-007 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:JANX-007 is under development for the treatment of...
-
Track & Monitor
New![]()
Internet of Things in medical: Head-mounted surgical cameras
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the medical industry’s Head-mounted surgical cameras within Internet of Things innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – HPN-217 in Refractory Multiple Myeloma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.HPN-217 in Refractory Multiple Myeloma Drug Details:HPN-217 is under development for the treatment of relapsed and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.